Stock AnalizRocket Lab Corp RKLB
Military/Government/Technical · IPO 2020 · data as of November 13, 2026
Rocket Lab Corp (RKLB) is a industrial company listed in the US with a market value of about $38.9B. In the twelve months to September 30, 2026 it had revenue of $882M and net income of -$227M, a net margin of -25.7%.
Its overall Stock Analiz score is 1.4 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 76% a year, a 5-year average ROIC of -15%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 99% below the current price.
Score: 1.4 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $882M | $602M | $436M | $245M | $211M | $62M | $35M |
| Net income | -$227M | -$198M | -$190M | -$183M | -$136M | -$117M | -$55M |
| Free cash flow | -$326M | -$322M | -$116M | -$154M | -$149M | -$97M | -$53M |
| EPS (diluted) | $-0.36 | $-0.37 | $-0.38 | $-0.38 | $-0.29 | $-0.56 | $-0.73 |
| Net margin | -25.7% | -32.9% | -43.6% | -74.6% | -64.4% | -188.5% | -156.4% |
| ROIC | — | -10.2% | -19.1% | -19.5% | -13.1% | -11.6% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 20 analysts is $93.10, 51% above the current price; targets range from $58.00 to $127.00; the consensus rating is “Buy”; expected EPS is $-0.31 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Rocket Lab stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 99% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Rocket Lab pay a dividend?
Not currently.
Is Rocket Lab a good stock to buy?
We do not give buy or sell advice. Rocket Lab scores 1.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.